Vivos Therapeutics VVOS
NASDAQ VVOS
$0.17 -0.01 (-5.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Vivos Therapeutics (VVOS) EBT Margin Growth (3y) (2023 - 2026)

Analysis

Vivos Therapeutics (VVOS) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Align Technology 11.30 Bn 10.20 Bn 757.43 Mn -304.00
2 Envista Holdings 4.38 Bn 3.26 Bn 407.00 Mn -17.00
3 Dentsply Sirona 2.27 Bn 2.03 Bn 493.00 Mn 354.00
4 Milestone Scientific 37.81 Mn 35.20 Mn 1.56 Mn 1,194.00
5 Dror Ortho-Design 9.77 Mn 9.68 Mn - -
6 Vivos Therapeutics 2.76 Mn 790,007.20 2.95 Mn 5,565.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,565.00
Mar 31, 2026 -10,661.00
Dec 31, 2025 -2,517.00
Sep 30, 2025 4,837.00
Jun 30, 2025 3,588.00
Mar 31, 2025 1,818.00
Dec 31, 2024 9,067.00
Sep 30, 2024 5,218.00
Jun 30, 2024 4,230.00
Mar 31, 2024 -1,148.00
Dec 31, 2023 5,701.00
Sep 30, 2023 -768.00
Jun 30, 2023 -11,895.00
Mar 31, 2023 3,723.00